About SLN Dividend Returns
Silence Therapeutics plc (SLN) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of SLN over the past year?
Silence Therapeutics plc (SLN) delivered a return of 20.89% over the past year. Since SLN does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in SLN be worth today?
A $10,000 investment in Silence Therapeutics plc one year ago would be worth $12,089 today, representing a gain of $2,089.
Q3Does SLN pay dividends?
Silence Therapeutics plc (SLN) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For SLN, the total return equals the price-only return.
Q4Did SLN beat the S&P 500?
Yes, Silence Therapeutics plc (SLN) outperformed the S&P 500 by 5.44 percentage points over the past year. SLN delivered a total return of 20.89%, compared to the S&P 500's 15.45%. This 5.44pp alpha means investors in SLN earned more than a passive S&P 500 index fund.
Q5What is SLN's worst drawdown?
Silence Therapeutics plc (SLN) experienced a maximum drawdown of -55.05% over the past year, declining from its peak on 2025-03-07 to its trough on 2025-04-09. The stock recovered to its prior peak by 2025-05-19. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is SLN's long-term total return over 10, 20, or 30 years?
Silence Therapeutics plc (SLN) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is -72.1% (-12.0% CAGR) — $10,000 would have grown to $2,790. Over 20 years: -72.1% total return (-6.2% CAGR) — $10,000 → $2,790. Over 30 years: -72.1% total return (-4.2% CAGR) — $10,000 → $2,790. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was SLN's best and worst year?
Silence Therapeutics plc's best calendar year was 2023 with a total return of 18.2%. Its worst year was 2024 with a total return of -62.9%. This range shows the volatility investors should expect — the difference between the best and worst year is 81.2 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).